Fallowfield L, Ratcliffe D, Jenkins V,et al. Psychiatric morbility and its recognition by doctors in patients with cancer[J]. Br J Cancer, 2001, 84(8): 1011-1015.
Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer[J]. N Engl J Med, 2001, 345(24): 1719-1726.
[5]
Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial[J]. Psycho-Oncology, 2007, 16(4): 277-286.
[6]
Kissane DW, Bloch S, Smith GC, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomized controlled trial[J]. Psychooncology, 2003, 12(6): 532-546.
[7]
Kissane DW, McKenzie M, Bloch S, et al. Family focused grief therapy: a randomized, controlled trial in palliative care and bereavement[J]. Am J Psychiatry, 2006, 163(7): 1208-1218.
[8]
Manne SL, Ostroff JS, Norton TR, et al. Cancer-related relationship communication in couples coping with early stage breast cancer[J]. Psychoonchology, 2006, 15(3): 234-247.
[9]
Breitbart W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer[J]. Support Care Cancer, 1995, 3(1): 45-60.
[10]
American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain[J]. JAMA, 1995, 274(23): 1874-1880.
[11]
Back AL, Arnold RM, Baile WF, et al. Approaching difficult communication tasks in oncology[J]. CA Cancer J Clin, 2005, 55(3): 164-177.
[12]
Ryan H, Schofield P, Cockburn J, et al. How to recognize and manage psychological distress in cancer patients[J]. Eur J Cancer Care(Engl), 2005, 14(1): 7-15.
[13]
Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study[J]. Arch Intern Med, 2000, 160(6): 786-794.
[14]
Misono S, Weiss NS, Fann JR, et al. Incidence of suicide in persons with cancer[J]. J Clin Oncol, 2008, 26(29): 4731-4738.
[15]
Miller M, Mogun H, Azrael D, et al. Cancer and the risk of suicide in older Americans[J]. J Clin Oncol, 2008, 26(29): 4720-4724.
[16]
Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life[J]. J Clin Oncol, 2002, 20(14): 3137-3148.
[17]
Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review[J]. Br J Cancer, 2006, 94(3): 372-390.
[18]
Wald TG, Kathol RG, Noyes R Jr, et al. Rapid relief of anxiety in cancer patients with both alprazolam and placebo[J]. Psychosomatics, 1993, 34(4): 324-332.
[19]
Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group[J]. J Clin Oncol, 2003, 21(10): 1937-1943.
[20]
Rankin NM, Barron JA, Lane LG, et al. Psychosocial oncology services in New South Wales[J]. Aust Health Rev, 2011, 35(2): 156-163.
Shneidman ES. Perspectives on suicidology: further reflections on suicide and psychache[J]. Suicide & life-threatening behavior, 1998, 28(3): 245-250.
[25]
Berlim MT, Mattevi BS, Pavanello DP, et al. Psychache and suicidality in adult mood disordered outpatients in Brazil[J]. Suicide Life Threat Behav, 2003, 33(3): 242-248.
[26]
Mitchell AJ. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis[J]. J Natl Compr Canc Netw, 2010, 8(4): 487-494.
[27]
Wang GL, Hsu SH, Feng AC, et al. The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan. Psychooncology[J]. 2011, 20(6): 639-646.
[28]
Carr D, Goudas L, Lawrence D, et al. Management of cancer symptoms: pain, depression, and fatigue[M]. Rockville(MD): Agency for Healthcare Research and Quality(US), 2002: 9-19.
[29]
Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site[J]. Psychoonchology, 2001, 10(1): 19-28.
[30]
Adler NE, Page NEK. Cancer care for the whole Patient: Meeting Psychosocial Health Needs[M]. Washington(DC): National Academies Press(US), 2008: 219-240.
[31]
Bultz BD, Holland JC. Emotional distress in patients with cancer: the sixth vital sign[J]. Commun Oncol, 2006, 3(5): 311-314.
[32]
Moorey S, Greer S,Bliss J, et al. A comparison of adjuvant psychological therapy and supportive counseling in patients with cancer[J]. Psychooncology, 1998, 7(3): 218-228.
[33]
Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behavior therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer, 2007, 97(5): 612-618.
[34]
Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes[J]. Nat Rev Cancer, 2007, 7(3): 192-201.
[35]
Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer[J]. Am J Hosp Palliat Care, 2006, 23(1): 35-40.
[36]
Kohli S, Fsher SG, Tra Y, et al. The effect of modafinil on cognitive function in breast cancer survivors[J]. Cancer, 2009, 115(12): 2605-2616.
[37]
Shaw EG, Rosdhal R, D’Agostino RB Jr, et al. Phase Ⅱ study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life[J].J Clin Oncol, 2006, 24(9): 1415-1420.
[38]
Ferguson RJ, Ahles TA, Saykin AJ, et al. Cognitive-behavioral management of chemotherapy-related cognitive change[J]. Psycho-onchology, 2007, 16(8): 772-777.
